Abstract
Background
In breast carcinomas treated with neoadjuvant chemotherapy, intraoperative identification of residual tumors may be difficult. A well-tolerated, low-diffusion charcoal suspension has been designed to tattoo breast tumors. In this study, we investigated whether this tattooing technique is efficient for localizing the tumor after treatment with chemotherapy.
Methods
In a series of 109 patients with large breast tumors, a 4% or 10% charcoal suspension was injected at the time of the initial biopsy before preoperative chemotherapy.
Results
Tolerance was good. After three or four cycles of chemotherapy, 91 patients underwent conservative treatment, and the surgical specimen was examined intraoperatively. The charcoal was detected in 94% of the cases. The charcoal was seen in the nodule or at the periphery in the surgical specimen without any acute inflammatory reaction or diffusion.
Conclusions
On the basis of these results, this micronized charcoal suspension at a defined granulometry and a concentration of 10% seems to be ideal for tattooing breast carcinomas over a period of 3 months in patients in whom neoadjuvant chemotherapy is planned.
Similar content being viewed by others
References
Mathieu MC, Rouzier R, Llombart-Cussac A, et al. The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile. Eur J Cancer 2004; 40:342–51
Wayne RW, Darby RE. Injection mammography. JAMA 1977; 237:2219–20
Czarnecki DJ, Feider HK, Splittgerber GF. Toluidine blue dye as a breast localization marker. Am J Roentgenol 1989; 261–3
Wyshoff H, Gastelblum A, Lenaerts L. Preoperative localization of nonpalpable breast lesions using the so-called harpoon technic. J Belge Radiol 1985; 68:275–80
Svane GA. Stereotaxic techniques for preoperative marking of non palpable breast lesions. Acta Radiol Diagn 1983; 24:145–51
Baron LF, Baron PL, Ackerman SJ, Durden DD, Pope TL Jr. Sonographically guided clip placement facilitates localization of breast cancer after neoadjuvant chemotherapy. Am J Roentgenol 2000; 174:539–40
Edeiken BS, Fornage BD, Bedi DG, et al. US-guided implantation of metallic markers for permanent localization of the tumor bed in patients with breast cancer who undergo preoperative chemotherapy. Radiology 1999; 213:895–900
Dash N, Chafin SH, Johnson RR, Contractor FM. Usefulness of tissue marker clips in patients undergoing neoadjuvant chemotherapy for breast cancer. AJR Am J Roentgenol 1999; 173:911–7
Park I, Genta RS, Romeo DP, Weesner RE. Colonic abscess and focal peritonitis secondary to india ink tattoing of the colon. Gastrointest Endosc 1991; 37:68–70
Coman E, Brandt LJ, Breener S, Franck M, Sabbay B, Benett B. Fat necrosis and inflammatory pseudotumor due to endoscopic tattoing of the colon with india ink. Gastrointest Endosc 1991; 37:65–8
Svane G. A stereotaxic technique for preoperative marking of non palpable breast lesions. Acta Radiol Diagn 1983; 24:145–51
Bonhomme L, Mathieu MC, Gosse C, et al. Charcoal tattoing of mammary carcinoma in mice. Int J Pharm 1992; 80:271–5
Mathieu MC, Bonhomme-Faivre L, Travagli JP, Seiller M, Contesso G. Presurgery labelling of breast tumours with a charcoal suspension for intratumour injection. J Oncol Pharm Practice 2001; 4:173–6
Naveau S, Bonhomme L, Preaux N, Chaput JC. A pure charcoal suspension for colonoscopic tattoo. Gastrointest Endosc 1991; 37:624–5
US Pharmacopeia. 22nd rev ed. Easton, PA: Mack Publishing, 1991:1483–7
US Pharmacopeia. 22nd rev ed. Easton, PA: Mack Publishing, 1991:1493–5
Bonhomme-Faivre L, Mathieu MC, Grossiord JL, et al. Formulation of a charcoal suspension for intratumor injection. Part 1. Study of the nature, granulometry, and concentration. Pharm Res 1997; 14:218–23
Bonhomme-Faivre L, Mathieu MC, Depraetere P, Grossiord JL, Seiller M. Formulation of a charcoal suspension for intratumoral injection: influence of the pluronic F68 concentration. Int J Pharm 1997; 152:251–5
Bonhomme L, Mathieu MC, Seiller M, Bretou M, Fredj G, Alarcon J. Charcoal labeling of mammary tumors in mice prior to chemotherapy and surgery. Eur J Pharm Sci 1993; 1:103–8
Bonhomme-Faivre L, Mathieu MC, Orbach-Arbouys S, Seiller M. Studies on toxicity of charcoal used in tattooing of tumors. Eur J Pharm Sci 1996; 4:95–100
Schwartz GF, Hortobagyi GN, Masood S, Palazzo J, Holland R, Page D. Consensus Conference Committee proceedings of the consensus conference on neoadjuvant chemotherapy in carcinoma of the breast, April 26–28, 2003, Philadelphia, PA. Hum Pathol 2004; 35:781–4
Acknowledgment
We thank Lorna Saint Ange for editing.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mathieu, MC., Bonhomme-Faivre, L., Rouzier, R. et al. Tattooing Breast Cancers Treated with Neoadjuvant Chemotherapy. Ann Surg Oncol 14, 2233–2238 (2007). https://doi.org/10.1245/s10434-006-9276-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-006-9276-5